The anti-angiogenic basis of metronomic chemotherapy

@article{Kerbel2004TheAB,
  title={The anti-angiogenic basis of metronomic chemotherapy},
  author={Robert S. Kerbel and Barton A. Kamen},
  journal={Nature Reviews Cancer},
  year={2004},
  volume={4},
  pages={423-436}
}
In addition to proliferating cancer cells and various types of normal cells, such as those of the bone marrow, conventional cytotoxic chemotherapeutics affect the endothelium of the growing tumour vasculature. The anti-angiogenic efficacy of chemotherapy seems to be optimized by administering comparatively low doses of drug on a frequent or continuous schedule, with no extended interruptions — sometimes referred to as 'metronomic' chemotherapy. In addition to reduced acute toxicity, the… CONTINUE READING
Highly Influential
This paper has highly influenced 28 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS

Citations

Publications citing this paper.
Showing 1-10 of 560 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 137 references

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

  • H Kato
  • N. Engl. J. Med. 350,
  • 2004

Addition of bevacizumab (rhuMab VEGF) to bolus IFL in the first line treatment of patients with metastatic colorectal cancer: results of a randomized phase III trial

  • H Hurwitz
  • N. Engl. J. Med
  • 2004

Similar Papers

Loading similar papers…